Dendritic cells (DCs) show the specific ability of processing and presenting exogenous antigens upon major histocompatibility class I (MHC I) molecules. This ability is called antigen cross-presentation (CP) and plays not only in the activation of naïve CD8 + T into anti-infectious and anti-tumoral cytotoxic CD8 + T cells, but also in the inactivation of self-acting naïve T cells by T cell anergy or T cells deletion. Since antigen CP was first described more than four decades ago, so many numbers of studies, by using different kinds of antigens and antigen-presenting cells (APCs), had been carried out to solve the molecular mechanism of CP. There are accumulating in vivo and in vitro evidences that endoplasmic reticulum (ER)-associated degradation (ERAD) acts as a key player in CP. But for all these efforts, the precious molecular mechanisms for CP are still remained to be elucidated. It may be partially because there are several pathways for CP running alongside with each other and each cell uses these several pathways redundantly responding against environmental conditions. Here, we review the intracellular transport routes for exogenous antigens and the subcellular compartment in which exogenous antigens undergo ERAD.
Introduction
MHC I molecules are expressed on the surface of all nucleated cells with short antigenic-peptides derived from endogenous proteins, which are degraded by the ubiquitin-proteasome system in the cytosol [1] . Subsequently these antigenic-peptides are transported into the ER trough transporter associated with antigen processing 1 (TAP1) and TAP2 and are loaded onto newly translated MHC I molecules. Then MHC I with antigenic-peptides is exported to the cell surface (DP; direct-presentation) [2] . The MHC I molecules with antigenic-peptides play a key component of the immune system as self-markers, enable CD8 + cytotoxic T lymphocytes (CTLs) to detect cancer cells or infectious agents by antigenic-peptides from non-self proteins. Non-self antigenic-peptides, which are derived from specific proteins from cancer cells or infectious agents, upon MHC I molecules are recognized by CTLs and lead to immune responses to destroy these non-self cells.
In contrast to MHC I, MHC class II (MHC II) is expressed only on APCs [3] . The antigenic-peptides presented upon class II peptides are derived from extracellular antigens, which are incorporated and digested in lysosomes by lysosomal proteases. MHC II molecules with antigenic-peptides interact with the CD4 + T helper cells, enable these CD4 + T helper T cells to trigger appropriate immune responses. In addition to MHC II, certain APCs are able to present extracellular antigens upon MHC I molecules. This phenomenon is called CP and plays critical roles in adaptive immunity [4] [5] [6] [7] [8] . Here, we review the most recent evidence about the intracellular trafficking pathways and the ERAD degradation of extracellular antigens in CP.
Roles of Cross-Presentation
CTLs derived from naïve CD8 + T cells, which had not encountered its cognate antigen within the periphery, but can respond to novel non-selves that the immune system has not yet came across. However, the numbers of naïve CD8 + T cells are too small and they cannot directly eliminate non-selves. To activate and propagate naïve CD8 + T cells into CTLs, two stimulations, MHC I with antigenic-peptide complexes and co-stimulatory molecules (CD40, CD80, CD86), by APCs are indispensable [9, 10] . But without help by CD4 + helper T cells, these helpless naïve CD8 + T cells will be wasted without producing memory T cells after temporary activation and propagation into CTLs [11] . Since memory T cells show faster and stronger immune responses against second encounter of the same non-selves, naïve CD8 + T cells would be differentiated into memory T cells after activation into CTL. In those purpose, APCs activate naïve CD8 + T cells and naïve CD4
+ T cells at the same time, indicating that antigenic-peptides from extracellular antigens are presented upon MHC I together with MHC II. In several kinds of cells, especially DCs, extracellular antigens can be internalized and presented onto MHC I molecules [12] [13] [14] together with MHC II molecules. Whereas CP also shows important roles in induction of tolerances against self-reacting naïve CD8 + T cells [15] . Those two roles, cross-priming and cross-tolerance, are the two sides of one coin; when CP is carried out by "activated DCs", which are stimulated by innate immunity or by helper CD4 + T cells, CP activates naïve CD8 + T cells and this process is described as cross-priming [16] [17] [18] . On the contrary, CP is accomplished by "steady-state" DCs without any stimulation, naïve CD8 + T cells are inactivated and this process is designated as cross-tolerance [15] .
Roles of DCs
DCs are bone marrow-derived cells present in almost whole tissues of our body, especially tissues in contact with the external environment. In immature state, DCs circulate whole of our body and incorporate extracellular antigens. After maturation, DCs migrate into lymph node and projects many branches to interact with T cells and B cells to show extents of incorporated extracellular antigens by both MHC I and class II. DCs act as commanders of the adaptive immune systems to initiate and to shape the immune response. But for the important roles of CP in the immune system, DCs comprehend heterogeneous series of subsets derived from different precursors and shows different functions. Most recent evidence has shown that only some subsets of DCs can make efficient CP [19, 20] . DCs are divided into three main populations: plasmacytoid DCs (pDCs), conventional DCs (cDCs), and monocyte derived DC (moDC) [21, 22] . cDCs are sub divided into several subsets by surface antigens. Among them, only CD8 + /CD103 + subset of cDC is capable of highest CP efficiency [23] . However moDC also shows efficient CP in vitro, their ability to activate naïve CD8 + T in vivo is remained to be elucidated [24, 25] . The contributions of the different DC subsets to cross-priming and cross-tolerance by CP are still controversial, because they dependent upon not only subsets, but also upon kinds of stimulation which activate them or maturation phases [26] .
In addition, several cell types were capable to show CP other than DCs; macrophages [27, 28] , B cells [29] , γδT cells [30] , mast cells [31] , endothelial cells [32] , and sinusoidal endothelial cells [33] . Though precious roles of these CP, especially by non-immune cell, are still not clarified, accumulating evidence in these days suggests that CP by endothelial cells causes tolerance upon CD8 + T cell [34] .
Pathways of processing of extracellular antigens in CP
Early studies on molecular mechanisms of CP find out two major pathways distinguished by proteases to process extracellular antigens: one is the proteasome pathway which is TAP-dependent and another is the endosome/lysosome pathway which is TAP-independent.
In the proteasome pathway, exogenous antigens are processed by the proteasome into antigenic-peptide precursors, which are transported by the TAP transporter into the ER [35] [36] [37] . Antigenic-peptides precursors are often longer polypeptides, longer N-terminus extrusions of peptides precursors are removed by cytosolic amino-peptidase (TPP2 [38] ) or ER resident amino-peptidases (ERAP1 and ERAP2 [39] . In the endosome/lysosome pathway, acidic lysosomal proteases, especially cathepsin S, generate the MHC I ligands precursors [40] . After processed by cathepsin S, longer N-terminus is trimmed by insulin-responsive amino-peptidase (IRAP) [41, 42] . In contrast to amino-peptidases, no exo-peptidase, which removes amino acids of antigenic peptide precursors from C-terminus (carboxy-peptidases), is detected in both pathways [43] . Because hydrophobic amino acids in the C-terminus of antigenic peptide precursors are essential for binding with MHC I and are called anchor residues, specific cleavage sites of each protease in both pathways, which determinate C-terminus amino acids of antigenic-peptides, implement definitive roles in determination of variety of antigenic-peptides for CP. In cell mediated-immunity, the antigenic-peptides of APCs by CP and the antigenic-peptides of target cells by DP must be consistent with each other. Since expressions of cathepsin S are restricted in APCs, in addition the variety of antigenic-peptide precursors from the endosome/lysosome pathway and those from the proteasome pathway are different with each other (Fig. 1) , antigenic-peptides from the endosome/lysosome pathway is rarely agreed with those from the proteasome pathway [44, 45] . These discordances together with graft rejection experiments strongly suggest that both pathways running together with each other, the endosome/lysosome pathway is considered to be less effective than proteasome-dependent CP [46] . Contrary to the difference of kinds of proteases, the pathways of the peptides loading on MHC I molecule are controversial. Classically, in the proteasome pathway free MHC I interacts with the peptide-loading complex (PLC) in ER; Calreticulin, ERp57 (PDI), Tapasin, and the peptide transporter TAP. After loading antigenic-peptide, the MHC I is released from the PLC and is transported to cell surface via Golgi apparatus. In these very complex processes, TAPs show monomorphic sequences, supplying a wide variety of peptides upon all alleles of the MHC I [47, 48] . The proximities of wide variety of peptides to the MHC I peptide binding groove are ensured by the PLC. Then a series of specific chaperons assist the correct folding of MHC I complex. All these process assure the varieties of antigenic-peptide upon MHC I. In the endosome/lysosome pathway, MHC I loading is carried out by peptide exchange reaction upon recycling of once peptide loaded MHC I from cell surface in endocytic acidic-vesicles. By peptide exchange reaction, antigenic-peptide of higher affinity with MHC I would be preferentially selected, and then assortment of antigenic-peptide had to be decreased. However in CP, accumulating evidence indicates that peptide loading on MHC I molecules is carried out not in the ER but rather in endocytic compartments. (i) TAP and the PLC are recruited to phagosomes or endosomes suggesting that peptide loading occur in endocytic compartments [49] [50] [51] .
(ii) A conserved tyrosine residue in cytosolic tail of MHC I is both required for internalization and for CP [52] . (iii) The trafficking pathway of newly synthesized MHC I molecules from the ER to endocytic compartments in DCs, which is promoted by CD74, is important for CP of cell-associated antigens [53] . All these results might indicate that the peptide loading in CP carried out in non-classical endocytic compartments, which also shows distinctive feature for the ER suggested by observations by optical microscopes and electron microscopes (Fig. 2 ) [50, [54] [55] [56] [57] .
Although the molecular mechanisms of the transport of ER-resident proteins into endosomes and phagosomes remain poorly understood. A recent finding gets a clue upon this question; the knockdown of Sec22b abrogated not only the delivery of ER-resident proteins to endocytic vesicles but also the transport of extracellular antigens into the cytosol, and resulted in defects in CP [58] , indicating Sec22b contributes the transport of ER-resident proteins into endocytic compartments.
Transport routes for extracellular antigens into cytosol in the proteasome pathway
The proteasome pathway requires transport of the exogenous antigens from the endocytic vesicles into the cytosol, regardless of the uptake route of the extracellular protein (receptor-mediated endocytosis, macro-pinocytosis or phagocytosis). This ability to export the extracellular protein into the cytosol [35] out of the endocytic compartments vesicles makes DCs to be outstanding APCs for CP. In this purpose DCs show marked contrast with macrophage. i), DCs prevent exogenous antigens from lysosomal degradation. ii), DCs transport exogenous antigens out of endocytic vesicles into the cytosol.
In order to avoid lysosomal degradation of exogenous antigens, DCs express low levels of lysosomal proteases [59] with protease inhibitors [59] by keeping endo/phagosomes under higher pH conditions [60, 61] , compared with macrophages and neutrophils [59] . Among several DC subsets, CP efficiency and amount of lysosomal proteases are inversely proportional [62, 63] . In addition to these circumstantial evidences, pharmacological inhibitors for endocytic acidification, chloroquine and ammonium chloride, and lysosomal protease inhibitors accelerate CP in human moDCs or cDC2 [64] [65] [66] . All these studies suggest that low level of protein degradation by lysosomal proteases is important for CP so as to preserve potential MHC I-binding epitopes. In spite of the essential role for retention of extracellular antigens for CP, the endocytic compartments for of antigen retention remain to be addressed in these days.
The first evidence indicating the transport of exogenous antigens from endocytic vesicles into the cytosol was shown by macrophage; macrophage engulfed the latex beads attached a ribosome-inactivating toxin brought about ribosomal defects and resulted in inhibition of protein synthesis, indicating that the toxin was exported from phagosome into the cytosol [54] . DCs show strong ability to transport extracellular antigens into cytosol, they even transfer cytochrome c into their cytosol to induce caspase-dependent apoptosis [67] . Although the molecular mechanisms of these specific pathways are still not described, in vivo and in vitro evidence was provided to designate ERAD corresponds with this export pathway.
ERAD designates as a cellular pathway, which recognizes specifically misfolded proteins in ER, retrograde-transport trough lipid bilayer to the cytoplasm afterward degrade them by the ubiquitin-proteasome system [68] [69] [70] . In this point of view, some ERAD related proteins, Sec61, VCP, and CHIP, are required for CP, supporting this model [55, 57, 71] . Sec61 is central element of the translocon, which is made up of three subunits (Sec61α, β, γ). VCP extracts misfolded proteins trough translocon across the membranes of the ER. CHIP is E3 ubiquitin ligase, which ubiquitinates unfolded proteins bound with molecular chaperone. Recently endogenous antigens are associated with cytosolic molecular chaperones after translocation to cytosol, Hsp70 [71] and Hsp90. In addition Hsp90 is also required for CP, Hsp90 recognizes the ERAD substrate in cytosol [72] [73] [74] . In Hsp90-deficient DCs, the amount of extracellular antigens, which is exported into cytosol, is decreased, and resultant apoptotic DCs after uptake of cytochrome c are decreased in vivo [75] . All above results strongly suggest that DCs employ the ERAD system to transport extracellular antigens out of endocytic compartments into cytosol (Fig. 2) . Although in CP endogenous antigens translated to cytosol through translocon, properly folded endogenous antigens will not be recognized by the ERAD system. In this context, endogenous antigens were associated with ER resident molecular chaperones in DC, indicating that endogenous antigens were unfolded in endocytic compartments [57] .
Purification of the subcellular compartment for ERAD of exogenous antigens
We have recently purified the subcellular compartment in which exogenous antigens undergo ERAD-like transport using moDCs derived cell line DC2.4 [71] . In this purified microsome, several amounts of bOVA were still retained in membranous fractions, but were transported out of microsome, ubiquitinated, and degraded in vitro reticulocyte lysates, ATP, and time dependent manner, indicating that ERAD-like transport and degradation of extracellular antigens are carried out in this purified microsome. This purified microsome contained both ER-resident proteins and endocytic compartment-specific proteins; ER-resident proteins (Sec61-α and GP96), MHC I and PLC proteins (Calreticulin, ERp57 (PDI), Tapasin, and the peptide transporter TAP1/2), ERAD-related proteins (CHIP, VCP, and proteasomes), and endocytic compartments-specific proteins (Lamp1 and Rab5). LAMP1 in this purified microsome showed both precursor form and mature form. All these results suggest that this fraction corresponds to the prospected non-classical endocytic compartment for CP, which also shows distinctive feature of the ER (Fig. 2) .
In cytosol, though the higher order structures of proteins prevent them from degradation by any peptidase, polypeptides are easily broken down by high activity of amino-peptidase [43] . So as to avoid restriction of peptide pools, ERAD degradation and peptide loading in CP would occur proximal area. In this context, our fraction equipped all the molecular apparatus for CP together in one compartments, insuring ERAD-like transport and degradation of extracellular antigens and antigenic-peptides loading upon MHC I. Further experiments will give us a clue to elucidate the molecular mechanism of CP especially about the vesicle transport system of DCs; (i) reconstitution of peptides loading using these purified microsome, (ii), confirmation of the Endo H sensitivity of MHC I, on which antigenic-peptide are loaded, (iii), proteomic analysis of this purified microsome.
Concluding Remarks
The role of the CP for cell-mediated immunity is well acknowledged. In contrast, molecular mechanisms for CP are still remained to be controversial. Recent findings showed that CP is largely based on the high flexible vesicle transport system in DCs. Vesicle transport pathway is ubiquitous but complicated process, because several redundant pathways running alongside with each other. To respond against environmental situations, cells change vesicle transport system flexibly to fit the situation. Consequently the fate of cellular protein changes dramatically as is the case of autophagy. It might be also the case for DCs; DCs alter their vesicle transport pathway responding to environmental conditions, such as ligation of pattern recognition receptors, cytokine conditions, etc. Subsequently, efficiency for CP would be affected. For instance signaling through pattern recognition receptors augment CP efficiency [76] . Next research, to clarify the molecules implicated in our purified microsome, will contribute to elucidate not only about the molecular mechanism of CP but also about the flexible vesicle transport system in DCs; it is of interest to investigate how immunological signaling pathways modify vesicle transport in DCs. These elucidations of molecular mechanisms of the vesicle transport pathway in DCs would contribute for effective CP, and be indispensable for the development of novel targeted vaccination strategies anti-cancer or anti-infectious diseases.
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